Coloplast A/S Beat Consensus Estimates

Coloplast A/S (CLPBY) reported earnings of $0.10 per share on revenue of $1.11 billion for the fiscal second quarter ended March 2026. The consensus earnings estimate was $0.09 per share. The company beat consensus estimates by 11.11% while revenue grew 13.55% on a year-over-year basis.

Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb?k, Denmark.